Dantrolene-induced hyperkalemia in a patient treated with diltiazem and metoprolol.
Yoganathan
T
T
Department of Cardiac Anesthesia, St. Joseph's Hospital and Medical Center, Paterson, NJ 07503, USA.
Casthely
P A
PA
Lamprou
M
M
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D002302:Cardiac Output / Q000187:drug effects; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000188:drug therapy; D003620:Dantrolene / Q000009:adverse effects*; D004110:Diltiazem / Q000009:adverse effects* / Q000627:therapeutic use; D004232:Diuretics / Q000008:administration & dosage; D004357:Drug Synergism; D005665:Furosemide / Q000008:administration & dosage; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D006947:Hyperkalemia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage; D008297:Male; D008305:Malignant Hyperthermia / Q000517:prevention & control; D008790:Metoprolol / Q000009:adverse effects* / Q000627:therapeutic use; D009125:Muscle Relaxants, Central / Q000009:adverse effects*; D011188:Potassium / Q000097:blood; D011669:Pulmonary Wedge Pressure / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D004232:Diuretics; D007004:Hypoglycemic Agents; D007328:Insulin; D009125:Muscle Relaxants, Central; D005665:Furosemide; D004110:Diltiazem; D003620:Dantrolene; D008790:Metoprolol; D005947:Glucose; D011188:Potassium